Carl-Johan Ehn appointed General Counsel and member of Vimian’s management team

Regulatory press release
Sep 07 2022

Carl-Johan Ehn appointed General Counsel and member of Vimian’s management team

Vimian appoints Carl-Johan Ehn as General Counsel and member of the Vimian Group management team as of 7 September 2022.

Carl-Johan Ehn has over two decades of experience from international law in the global pharmaceutical industry at Zoetis and Pfizer, as well as from Mannheimer Swartling law firm. He joins Vimian from animal health company Zoetis where he held various leading positions over the past nine years, most recently as Chief Counsel for its international operations. The General Counsel is a new addition to the Vimian Group management team and will focus on supporting the company in the execution of commercial strategies, and ensuring high corporate governance and compliance standards.

“Carl-Johan Ehn brings a wealth of international experience from the sector and across a wide variety of legal topics. He will be a key addition to our team as we continue build a global, leading animal health company in a public environment”, says Fredrik Ullman, CEO of Vimian Group.

Carl-Johan Ehn joined Vimian on 15 August and was appointed member of the Vimian Group management team on 7 September.

About Vimian

Vimian is a global, fast-growing group of innovation-driven companies with a shared passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to veterinary professionals, labs and pet parents around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact by improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies reach over 15,000 customers in +150 markets, employ more than 700 people and have a combined annual turnover of approximately EUR 170 million. FNCA Sweden AB is appointed the Company’s Certified Adviser, info@fnca.se, +46 (0) 8-528 00 399. For more information, please visit: www.vimian.com.